Your browser doesn't support javascript.
loading
Immunoexpression of BAP1, ROS1, and ALK in Spitzoid Melanocytic Tumors.
Cardili, Leonardo; Viana, Cristiano Ribeiro; Germano, Andressa; Fernandes, Mariana; Barcellos, Denise; Landman, Gilles.
Afiliação
  • Cardili L; 1 Instituto do Câncer do Estado de São Paulo, São Paulo, Brazil.
  • Viana CR; 2 Universidade Federal de São Paulo, São Paulo, Brazil.
  • Germano A; 3 Hospital do Câncer de Barretos/Fundação Pio XII, Barretos, Brazil.
  • Fernandes M; 2 Universidade Federal de São Paulo, São Paulo, Brazil.
  • Barcellos D; 2 Universidade Federal de São Paulo, São Paulo, Brazil.
  • Landman G; 2 Universidade Federal de São Paulo, São Paulo, Brazil.
Int J Surg Pathol ; 26(6): 514-520, 2018 Sep.
Article em En | MEDLINE | ID: mdl-29623743
BACKGROUND: Spitzoid tumors are a heterogeneous group of melanocytic neoplasms that frequently imposes diagnostic difficulties. Lately, several advances in molecular biology afforded significant discoveries on the pathogenesis of these tumors. BAP1 (BRCA-1 associated protein-1) inactivation and anomalous expression of kinase translocation-related proteins are among the main criteria launched by new classification proposals. Our aim was to systematically assess the immunoexpression of BAP1, ROS1 (receptor tyrosine kinase c-Ros oncogene 1), and ALK (anaplastic lymphoma receptor tyrosine kinase) proteins in an unpublished series of spitzoid tumors. METHODS: Retrospective study based on 47 formalin-fixed paraffin-embedded tissue samples from 3 different institutions. BAP1, ROS1, and ALK immunostains were performed in all cases. We included 27 Spitz tumors without significant abnormality, 15 atypical spitzoid tumors, and 5 spitzoid melanomas. RESULTS: We observed loss of BAP1 nuclear immunolabeling in 4.3% of evaluable cases (2/46), both of them atypical spitzoid tumors. The proportional frequency of BAP1-inactivated cases among atypical spitzoid tumors was 14.2% (2/14). No immunoexpression of ROS1 or ALK was found. CONCLUSIONS: Our study revealed 2 additional BAP1-inactived cases and described its respective frequency. The absence of anomalous expression of translocation-related proteins ALK and ROS1 in this series, composed predominantly of low-grade/low-risk tumors, indicates that translocated spitzoid lesions may not be as prevalent as initially suggested, at least in some populations. Furthermore, our findings encourage additional investigation on unequal occurrence of such immunomarkers among different diagnostic categories of spitzoid neoplasms.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Cutâneas / Proteínas Tirosina Quinases / Proteínas Proto-Oncogênicas / Receptores Proteína Tirosina Quinases / Nevo de Células Epitelioides e Fusiformes / Proteínas Supressoras de Tumor / Ubiquitina Tiolesterase Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Adolescent / Adult / Child / Child, preschool / Female / Humans / Infant / Male / Middle aged Idioma: En Revista: Int J Surg Pathol Assunto da revista: PATOLOGIA Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Brasil País de publicação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Cutâneas / Proteínas Tirosina Quinases / Proteínas Proto-Oncogênicas / Receptores Proteína Tirosina Quinases / Nevo de Células Epitelioides e Fusiformes / Proteínas Supressoras de Tumor / Ubiquitina Tiolesterase Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Adolescent / Adult / Child / Child, preschool / Female / Humans / Infant / Male / Middle aged Idioma: En Revista: Int J Surg Pathol Assunto da revista: PATOLOGIA Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Brasil País de publicação: Estados Unidos